Purple Biotech Ltd
PPBT
$2.42
-$0.0363-1.48%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | 23.12% | 2.52% | 8.25% | |
| Total Depreciation and Amortization | -- | -0.51% | 1.53% | -1.99% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -260.01% | -185.50% | -134.94% | |
| Change in Net Operating Assets | -- | 608.82% | 523.44% | -91.58% | |
| Cash from Operations | -- | 7.46% | -7.64% | -19.06% | |
| Capital Expenditure | -- | 110.00% | 100.00% | 88.46% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -93.98% | -91.34% | -12.57% | |
| Cash from Investing | -- | -92.95% | -89.26% | -30.30% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -5.42% | -3.64% | -1.82% | |
| Issuance of Common Stock | -- | -6.14% | -7.28% | 4.34% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | 1,603.32% | 1,547.52% | 1,951.14% | |
| Cash from Financing | -- | 328.16% | 348.44% | 389.14% | |
| Foreign Exchange rate Adjustments | -- | -61.54% | 102.78% | 135.29% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -434.11% | -619.35% | -113.07% | |